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Background: The optimal revascularization strategy in patients with multivessel coronary artery disease (MVCAD) presenting with acute myocardial 
infarction (AMI) complicated by cardiogenic shock (CS) is unknown.
Methods: We evaluated outcomes of patients with MVCAD and AMI complicated by CS at a tertiary care center who underwent PCI from 
01/01/2002-6/30/2010 (n=223). CS was defined prospectively based on the NCDR definition. Kaplan Meier estimations were used to assess 
differences in survival between patients treated with single vessel PCI (SVPCI) and multivessel PCI (MVPCI). Since AMI with CS has an early hazard, a 
multiphase survival model was used to adjust for differences in the groups.
Results: 72% (n=177) of patients were treated with SVPCI and 21% with MVPCI (n=46). Baseline characteristics including age, sex, BMI, blood 
pressure, IABP, and comorbidities (i.e. diabetes) were similar between groups. At 1 year, patients treated with MVPCI had lower survival when 
compared to SVPCI (39% vs 61%); however, this difference was attenuated over 8 years of follow-up (Figure). After adjusting for relevant baseline 
characteristics, MVPCI was associated with higher risk of mortality within the 1st year (HR 1.8, p=0.02) but not after the 1st year (p=0.77).
Conclusion: In patients with MVCAD and AMI complicated by CS, both SVPCI and MVPCI are associated with high early mortality. MVPCI is 
associated with higher early death as compared to SVPCI; however, the association is attenuated over time.
 
